OrbiMed Announces New General Partner

NEW YORK, May 9, 2018 – OrbiMed is pleased to announce the promotion of C. Scotland Stevens to General Partner. Scot joins the firm’s five existing General Partners, Sven H. Borho, Carl L. Gordon, Jonathan T. Silverstein, W. Carter Neild and Geoffrey C. Hsu.

Scot joined OrbiMed in 2005 from Goldman, Sachs & Co., and in recent years has led the firm’s trading activities and derivatives investment strategies. Scot has provided strong leadership across the firm, in particular for OrbiMed’s public equity and hedge fund team. The addition of Scot as a General Partner is an expression of OrbiMed's commitment to strengthening the organization for the long term.

“Scot is a consummate professional and team leader, elevating those around him.” said Managing Member Sven H. Borho. “We are proud to have him as a new General Partner and leader of the firm.”

Scot can be reached at (212) 739-6400 or StevensS@OrbiMed.com.

About OrbiMed
OrbiMed is a leading healthcare investment firm, with $18 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

Carter Neild, CFA
Phone: (212) 739.6400
Email: NeildC@OrbiMed.com

img img img img img img img img img